Dow Down0.22% Nasdaq Up0.14%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
2.50 Up 0.04(1.63%) Aug 22, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 399   97   -  
Cost of Revenue -   -   -  
Gross Profit 399   97   -  
Operating Expenses
Research Development17,651  10,451  6,190  
Selling General and Administrative3,697  2,621  6,146  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (20,949) (12,975) (12,770)
Income from Continuing Operations
Total Other Income/Expenses Net -  125  2,551  
Earnings Before Interest And Taxes(20,925)(12,880)(10,219)
Interest Expense -   -   -  
Income Before Tax(20,925)(12,880)(10,219)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(20,925)(12,880)(10,219)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (20,925) (12,880) (10,219)
Preferred Stock And Other Adjustments(8,610)(12,815) -  
Net Income Applicable To Common Shares (29,535) (25,695) (10,219)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.